Company intelligence / Profile preview

HealthCap

Ownership: Private
Employees: ~26
Development stage: Other

Overview

HealthCap is one of Europe’s largest and most active venture capital firms specializing in life sciences. Since its founding in 1996, it has raised over €1.2 billion across eight funds and invested in more than 130 companies globally. Its portfolio spans pharmaceuticals, biotechnology, medical devices, and digital health with a focus on breakthrough therapies for diseases with high unmet medical need. Over 45 of its portfolio companies have gone public and more than 30 pharmaceutical products developed by HealthCap-backed firms have received market approval.

Industry: Investors

Partnerships

Johnson & Johnson Innovation (JJDC) – co-lead investment in Fusion Pharmaceuticals

Beyond the preview

Go deeper on HealthCap.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HealthCap.

Explore the full profile